Skip to main content
Top
Published in: European Radiology 6/2016

01-06-2016 | Gastrointestinal

Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOB-DTPA-enhanced liver MR imaging

Authors: Jeong Hee Yoon, Jeong Min Lee, Munyoung Paek, Joon Koo Han, Byung Ihn Choi

Published in: European Radiology | Issue 6/2016

Login to get access

Abstract

Objectives

To determine whether multislice T1 mapping of the liver using a modified look-locker inversion recovery (MOLLI) sequence on gadoxetic acid-enhanced magnetic resonance imaging (MRI) can be used as a quantitative tool to estimate liver function and predict the presence of oesophageal or gastric varices.

Methods

Phantoms filled with gadoxetic acid were scanned three times using MOLLI sequence to test repeatability. Patients with chronic liver disease or liver cirrhosis who underwent gadoxetic acid-enhanced liver MRI including MOLLI sequence at 3 T were included (n = 343). Pre- and postcontrast T1 relaxation times of the liver (T1liver), changes between pre- and postcontrast T1liver (ΔT1liver), and adjusted postcontrast T1liver (postcontrast T1liver-T1spleen/T1spleen) were compared among Child-Pugh classes. In 62 patients who underwent endoscopy, all T1 parameters and spleen sizes were correlated with varices.

Results

Phantom study showed excellent repeatability of MOLLI sequence. As Child-Pugh scores increased, pre- and postcontrast T1liver were significantly prolonged (P < 0.001), and ΔT1liver and adjusted postcontrast T1liver decreased (P < 0.001). Adjusted postcontrast T1liver and spleen size were independently associated with varices (R 2 = 0.29, P < 0.001).

Conclusions

T1 mapping of the liver using MOLLI sequence on gadoxetic acid-enhanced MRI demonstrated potential in quantitatively estimating liver function, and adjusted postcontrast T1liver was significantly associated with varices.

Key Points

• T1 mapping using MOLLI sequence can be achieved within a breath-hold.
• T1liver measured by MOLLI sequence provided excellent short-term repeatability.
• Precontrast and postcontrast T1liver were significantly prolonged as Child-Pugh scores increased.
• Adjusted postcontrast T1liver and spleen size were independently associated with varices.
Literature
2.
go back to reference Kwon A, Ha‐Kawa SK, Uetsuji S, Inoue T, Matsui Y, Kamiyama Y (1997) Preoperative determination of the surgical procedure for hepatectomy using technetium‐99m‐galactosyl human serum albumin (99mTc‐GSA) liver scintigraphy. Hepatology 25:426–429CrossRefPubMed Kwon A, Ha‐Kawa SK, Uetsuji S, Inoue T, Matsui Y, Kamiyama Y (1997) Preoperative determination of the surgical procedure for hepatectomy using technetium‐99m‐galactosyl human serum albumin (99mTc‐GSA) liver scintigraphy. Hepatology 25:426–429CrossRefPubMed
3.
go back to reference Vauthey J-N, Chaoui A, Do K-A et al (2000) Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 127:512–519CrossRefPubMed Vauthey J-N, Chaoui A, Do K-A et al (2000) Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 127:512–519CrossRefPubMed
4.
go back to reference Kokudo N, Vera DR, Tada K et al (2002) Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis. World J Surg 26:1342–1347CrossRefPubMed Kokudo N, Vera DR, Tada K et al (2002) Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis. World J Surg 26:1342–1347CrossRefPubMed
5.
go back to reference Dinant S, de Graaf W, Verwer BJ et al (2007) Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med 48:685–692CrossRefPubMed Dinant S, de Graaf W, Verwer BJ et al (2007) Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med 48:685–692CrossRefPubMed
6.
go back to reference de Graaf W, van Lienden KP, van Gulik TM, Bennink RJ (2010) 99mTc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy. J Nucl Med 51:229–236CrossRefPubMed de Graaf W, van Lienden KP, van Gulik TM, Bennink RJ (2010) 99mTc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy. J Nucl Med 51:229–236CrossRefPubMed
7.
go back to reference Kudo M (2010) Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma? Oncology 78(Suppl 1):87–93CrossRefPubMed Kudo M (2010) Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma? Oncology 78(Suppl 1):87–93CrossRefPubMed
8.
go back to reference Inoue T, Kudo M, Komuta M et al (2012) Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT. J Gastroenterol 47:1036–1047CrossRefPubMed Inoue T, Kudo M, Komuta M et al (2012) Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT. J Gastroenterol 47:1036–1047CrossRefPubMed
9.
go back to reference Granito A, Galassi M, Piscaglia F et al (2013) Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study. Aliment Pharmacol Ther 37:355–363CrossRefPubMed Granito A, Galassi M, Piscaglia F et al (2013) Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study. Aliment Pharmacol Ther 37:355–363CrossRefPubMed
10.
go back to reference Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE, Choi JY (2010) Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Radiology 255:459–466CrossRefPubMed Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE, Choi JY (2010) Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Radiology 255:459–466CrossRefPubMed
11.
go back to reference Nilsson H, Blomqvist L, Douglas L et al (2013) Gd-EOB-DTPA-enhanced MRI for the assessment of liver function and volume in liver cirrhosis. British J Radiol 86:20120653 doi: 20120610.20121259/bjr.20120653 Nilsson H, Blomqvist L, Douglas L et al (2013) Gd-EOB-DTPA-enhanced MRI for the assessment of liver function and volume in liver cirrhosis. British J Radiol 86:20120653 doi: 20120610.20121259/bjr.20120653
12.
go back to reference Nishie A, Ushijima Y, Tajima T et al (2012) Quantitative analysis of liver function using superparamagnetic iron oxide-and Gd-EOB-DTPA-enhanced MRI: Comparison with Technetium-99m galactosyl serum albumin scintigraphy. Eur J Radiol 81:1100–1104CrossRefPubMed Nishie A, Ushijima Y, Tajima T et al (2012) Quantitative analysis of liver function using superparamagnetic iron oxide-and Gd-EOB-DTPA-enhanced MRI: Comparison with Technetium-99m galactosyl serum albumin scintigraphy. Eur J Radiol 81:1100–1104CrossRefPubMed
13.
go back to reference Yamada A, Hara T, Li F et al (2011) Quantitative evaluation of liver function with use of gadoxetate disodium–enhanced MR imaging. Radiology 260:727–733CrossRefPubMed Yamada A, Hara T, Li F et al (2011) Quantitative evaluation of liver function with use of gadoxetate disodium–enhanced MR imaging. Radiology 260:727–733CrossRefPubMed
14.
go back to reference Van Beers BE, Pastor CM, Hussain HK (2012) Primovist, eovist: what to expect? J Hepatol 57:421–429CrossRefPubMed Van Beers BE, Pastor CM, Hussain HK (2012) Primovist, eovist: what to expect? J Hepatol 57:421–429CrossRefPubMed
15.
go back to reference Tsuda N, Matsui O (2010) Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi—gadoxetic acid–enhanced mr imaging 1. Radiology 256:767–773CrossRefPubMed Tsuda N, Matsui O (2010) Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi—gadoxetic acid–enhanced mr imaging 1. Radiology 256:767–773CrossRefPubMed
16.
go back to reference Bae KE, Kim SY, Lee SS et al (2012) Assessment of hepatic function with Gd-EOB-DTPA-enhanced hepatic MRI. Dig Dis 30:617–622CrossRefPubMed Bae KE, Kim SY, Lee SS et al (2012) Assessment of hepatic function with Gd-EOB-DTPA-enhanced hepatic MRI. Dig Dis 30:617–622CrossRefPubMed
17.
go back to reference Katsube T, Okada M, Kumano S et al (2011) Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest Radiol 46:277–283CrossRefPubMed Katsube T, Okada M, Kumano S et al (2011) Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest Radiol 46:277–283CrossRefPubMed
18.
go back to reference Messroghli DR, Greiser A, Fröhlich M, Dietz R, Schulz‐Menger J (2007) Optimization and validation of a fully‐integrated pulse sequence for modified look‐locker inversion‐recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging 26:1081–1086CrossRefPubMed Messroghli DR, Greiser A, Fröhlich M, Dietz R, Schulz‐Menger J (2007) Optimization and validation of a fully‐integrated pulse sequence for modified look‐locker inversion‐recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging 26:1081–1086CrossRefPubMed
19.
go back to reference Nacif MS, Turkbey EB, Gai N et al (2011) Myocardial T1 mapping with MRI: comparison of look‐locker and MOLLI sequences. J Magn Reson Imaging 34:1367–1373CrossRefPubMedPubMedCentral Nacif MS, Turkbey EB, Gai N et al (2011) Myocardial T1 mapping with MRI: comparison of look‐locker and MOLLI sequences. J Magn Reson Imaging 34:1367–1373CrossRefPubMedPubMedCentral
21.
go back to reference Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG (2008) The management of portal hypertension: rational basis, available treatments and future options. J Hepatol 48:S68–S92CrossRefPubMed Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG (2008) The management of portal hypertension: rational basis, available treatments and future options. J Hepatol 48:S68–S92CrossRefPubMed
22.
go back to reference Cohen JA, Kaplan MM (1979) The SGOT/SGPT ratio—an indicator of alcoholic liver disease. Dig Dis Sci 24:835–838CrossRefPubMed Cohen JA, Kaplan MM (1979) The SGOT/SGPT ratio—an indicator of alcoholic liver disease. Dig Dis Sci 24:835–838CrossRefPubMed
23.
go back to reference Levitsky J, Mailliard ME (2004) Diagnosis and therapy of alcoholic liver disease. Semin Liver Dis 24:233–247CrossRefPubMed Levitsky J, Mailliard ME (2004) Diagnosis and therapy of alcoholic liver disease. Semin Liver Dis 24:233–247CrossRefPubMed
24.
go back to reference Yoon JH, Lee JM, Han JK, Choi BI (2014) Shear wave elastography for liver stiffness measurement in clinical sonographic examinations evaluation of intraobserver reproducibility, technical failure, and unreliable stiffness measurements. J Ultrasound Med 33:437–447CrossRefPubMed Yoon JH, Lee JM, Han JK, Choi BI (2014) Shear wave elastography for liver stiffness measurement in clinical sonographic examinations evaluation of intraobserver reproducibility, technical failure, and unreliable stiffness measurements. J Ultrasound Med 33:437–447CrossRefPubMed
25.
go back to reference Kudo M, Zheng RQ, Kim SR et al (2008) Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. Intervirology 51:17–26CrossRefPubMed Kudo M, Zheng RQ, Kim SR et al (2008) Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. Intervirology 51:17–26CrossRefPubMed
26.
go back to reference Messroghli DR, Plein S, Higgins DM et al (2006) human myocardium: single-breath-hold mr t1 Mapping with High Spatial Resolution—Reproducibility Study1. Radiology 238:1004–1012CrossRefPubMed Messroghli DR, Plein S, Higgins DM et al (2006) human myocardium: single-breath-hold mr t1 Mapping with High Spatial Resolution—Reproducibility Study1. Radiology 238:1004–1012CrossRefPubMed
27.
go back to reference Kim KA, Park MS, Kim IS et al (2012) Quantitative evaluation of liver cirrhosis using T1 relaxation time with 3 tesla MRI before and after oxygen inhalation. J Magn Reson Imaging 36:405–410CrossRefPubMed Kim KA, Park MS, Kim IS et al (2012) Quantitative evaluation of liver cirrhosis using T1 relaxation time with 3 tesla MRI before and after oxygen inhalation. J Magn Reson Imaging 36:405–410CrossRefPubMed
28.
go back to reference Xl C, Tw C, Zl L et al (2013) Spleen size measured on enhanced mri for quantitatively staging liver fibrosis in minipigs. J Magn Reson Imaging 38:540–547CrossRef Xl C, Tw C, Zl L et al (2013) Spleen size measured on enhanced mri for quantitatively staging liver fibrosis in minipigs. J Magn Reson Imaging 38:540–547CrossRef
29.
go back to reference Barnhart HX, Barboriak DP (2009) Applications of the repeatability of quantitative imaging biomarkers: a review of statistical analysis of repeat data sets. Transl Oncol 2:231–235CrossRefPubMedPubMedCentral Barnhart HX, Barboriak DP (2009) Applications of the repeatability of quantitative imaging biomarkers: a review of statistical analysis of repeat data sets. Transl Oncol 2:231–235CrossRefPubMedPubMedCentral
30.
go back to reference Planchamp C, Montet X, Frossard J-L et al (2005) Magnetic resonance imaging with hepatospecific contrast agents in cirrhotic rat livers. Investig Radiol 40:187–194CrossRef Planchamp C, Montet X, Frossard J-L et al (2005) Magnetic resonance imaging with hepatospecific contrast agents in cirrhotic rat livers. Investig Radiol 40:187–194CrossRef
31.
go back to reference Yoneyama T, Fukukura Y, Kamimura K et al (2013) Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function. Eur Radiol 24:857–865CrossRefPubMed Yoneyama T, Fukukura Y, Kamimura K et al (2013) Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function. Eur Radiol 24:857–865CrossRefPubMed
32.
go back to reference Kötz B, West C, Saleem A, Jones T, Price P (2009) Blood flow and Vd (water): both biomarkers required for interpreting the effects of vascular targeting agents on tumor and normal tissue. Mol Cancer Ther 8:303–309CrossRefPubMed Kötz B, West C, Saleem A, Jones T, Price P (2009) Blood flow and Vd (water): both biomarkers required for interpreting the effects of vascular targeting agents on tumor and normal tissue. Mol Cancer Ther 8:303–309CrossRefPubMed
33.
go back to reference de Franchis R (2006) Noninvasive diagnosis of esophageal varices: is it feasible&quest. Am J Gastroenterol 101:2520–2522CrossRefPubMed de Franchis R (2006) Noninvasive diagnosis of esophageal varices: is it feasible&quest. Am J Gastroenterol 101:2520–2522CrossRefPubMed
34.
go back to reference Berzigotti A, Seijo S, Arena U et al (2013) Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology 144:102–111CrossRefPubMed Berzigotti A, Seijo S, Arena U et al (2013) Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology 144:102–111CrossRefPubMed
35.
go back to reference Motosugi U, Ichikawa T, Sou H et al (2009) Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: Which biological markers of the liver function affect the enhancement? J Magn Reson Imaging 30:1042–1046CrossRefPubMed Motosugi U, Ichikawa T, Sou H et al (2009) Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: Which biological markers of the liver function affect the enhancement? J Magn Reson Imaging 30:1042–1046CrossRefPubMed
36.
go back to reference Heye T, Yang S-R, Bock M et al (2012) MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis. Eur Radiol 22:1224–1232CrossRefPubMed Heye T, Yang S-R, Bock M et al (2012) MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis. Eur Radiol 22:1224–1232CrossRefPubMed
37.
go back to reference de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC (2004) MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results1. Radiology 230:652–659CrossRefPubMed de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC (2004) MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results1. Radiology 230:652–659CrossRefPubMed
38.
39.
go back to reference Liberman G, Louzoun Y, Ben Bashat D (2014) T1 Mapping using variable flip angle SPGR data with flip angle correction. J Magn Reson Imaging 40:171–180CrossRefPubMed Liberman G, Louzoun Y, Ben Bashat D (2014) T1 Mapping using variable flip angle SPGR data with flip angle correction. J Magn Reson Imaging 40:171–180CrossRefPubMed
40.
go back to reference Nilsson H, Blomqvist L, Douglas L, Nordell A, Jonas E (2010) Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI. HPB 12:567–576CrossRefPubMedPubMedCentral Nilsson H, Blomqvist L, Douglas L, Nordell A, Jonas E (2010) Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI. HPB 12:567–576CrossRefPubMedPubMedCentral
41.
go back to reference Leinhard OD, Dahlström N, Kihlberg J et al (2012) Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study. Eur Radiol 22:642–653CrossRef Leinhard OD, Dahlström N, Kihlberg J et al (2012) Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study. Eur Radiol 22:642–653CrossRef
42.
go back to reference Saito K, Ledsam J, Sourbron S et al (2013) Assessing liver function using dynamic Gd‐EOB‐DTPA‐enhanced MRI with a standard 5‐phase imaging protocol. J Magn Reson Imaging 37:1109–1114CrossRefPubMed Saito K, Ledsam J, Sourbron S et al (2013) Assessing liver function using dynamic Gd‐EOB‐DTPA‐enhanced MRI with a standard 5‐phase imaging protocol. J Magn Reson Imaging 37:1109–1114CrossRefPubMed
43.
go back to reference Stockmann M, Lock JF, Malinowski M, Niehues SM, Seehofer D, Neuhaus P (2010) The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB 12:139–146CrossRefPubMedPubMedCentral Stockmann M, Lock JF, Malinowski M, Niehues SM, Seehofer D, Neuhaus P (2010) The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB 12:139–146CrossRefPubMedPubMedCentral
44.
go back to reference Fan S, Wang Q, Lo C, Yu K, Lai E, Wong J (1994) Evaluation of indocyanine green retention and aminopyrine breath tests in patients with malignant biliary obstruction. Aust N Z J Surg 64:759–762CrossRefPubMed Fan S, Wang Q, Lo C, Yu K, Lai E, Wong J (1994) Evaluation of indocyanine green retention and aminopyrine breath tests in patients with malignant biliary obstruction. Aust N Z J Surg 64:759–762CrossRefPubMed
Metadata
Title
Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOB-DTPA-enhanced liver MR imaging
Authors
Jeong Hee Yoon
Jeong Min Lee
Munyoung Paek
Joon Koo Han
Byung Ihn Choi
Publication date
01-06-2016
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 6/2016
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-015-3994-7

Other articles of this Issue 6/2016

European Radiology 6/2016 Go to the issue